Login / Signup

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.

Ting Yan ShiSheng YinJian Qing ZhuPing ZhangJi-Hong LiuYaping ZhuSufang WuXiao-Jun ChenXipeng WangYincheng TengTao ZhuAijun YuYingli ZhangYanling FengHe HuangXiujuan ZhaoYanli LiWei JiangPing ZhangJiarui LiZhihong AiWei ZhangHuixun JiaYuqin ZhangRong JiangJiejie ZhangWen GaoYuting LuanRong Yu Zang
Published in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT03983226.
Keyphrases
  • minimally invasive
  • coronary artery bypass
  • clinical trial
  • coronary artery disease
  • surgical site infection
  • acute coronary syndrome